The president also blamed the painkiller Tylenol for autism, but the evidence doesn’t stack up at all.

Forget the glorious successes of past breakthroughs—the real justification for research investment is what we get for our money. Here’s what economists say.

With powerful video generation tools now in the hands of more people than ever, let's take a look at how they work.

While letting AI take the wheel and write the code for your website may seem like a good idea, it’s not without its limitations.

With news this week of the messaging app being used to discuss war plans, we get you up to speed on what Signal should be used for—and what it shouldn’t.

How companies reach their emissions goals is more important than how fast.

The tendency to make things up is holding chatbots back. But that’s just what they do.

Google’s new AI search feature is a mess. So why is it telling us to eat rocks and gluey pizza, and can it be fixed?

By orchestrating EVs, batteries, and smart home devices, VPPs can help make the grid cleaner and more efficient.

Three key issues that jeopardized the EU AI Act

Can AI create a life form? These “generative” genomes are a start

Artificial intelligence can design toxins that evade security controls.

India is OpenAI’s second-largest market, but ChatGPT and Sora reproduce caste stereotypes that harm millions of people.

Some companies are working to remedy the issue.

The risks posed when kids form bonds with chatbots have turned AI safety from an abstract worry into a political flashpoint. What happens now?

The uncanny valley is narrowing. Are we ready for what comes next?

Marcin Jakubowski is compiling a DIY set of society’s essential machines and making it open-source.

AI companies are revealing the one number that researchers have long sought. What comes next?

Flock Safety is pitching its police-style drone program to private businesses. It could bring aerial surveillance to shopping centers, warehouses, and hospitals.

With the new Edward and Joyce Linde Music Building, the Institute’s multidisciplinary approach to music deepens.

At MIT’s Formaggio Lab, Peña’s work may help researchers pinpoint the elusive particle’s mass—and refine the fundamental laws of physics in the process.

Baafour Asiamah-Adjei ’03 is working to transform West Africa’s energy landscape—and investing in the people who will shape the region’s future.

Imagine synthetic bacterial supplements that could regulate the gut microbiome, controlled via Bluetooth to treat conditions from irritable bowel syndrome to depression. What could go wrong?

When Alfred E. Burton was appointed MIT’s first dean in 1902, he was already known for leading research expeditions to the Arctic and the jungle. Naturally, students adored him.

A new method can physically restore original paintings using digitally constructed films.

An atmospheric water harvester based on an origami-inspired hydrogel works anywhere—even Death Valley.

A new implant for diabetics carries a reservoir of glucagon that can be stored under the skin and released manually or automatically—no injections needed.

A supercharged vaccine that remains in the lymph nodes for weeks is likelier to generate more antibody variations, strengthening the immune response.

Global shifts, advancing tech, and data center demand: Here’s what’s coming in 2025 and beyond.

You already know that agents and small language models are the next big things. Here are five other hot trends you should watch out for this year.

The US still has no federal privacy law. But recent enforcement actions against data brokers may offer some new protections for Americans’ personal information.

What happens in the US, however, will depend a lot on the incoming Trump administration.

The Space Launch System is facing fresh calls for cancellation, but it still has a key role to play in NASA’s return to the moon.

Police drones, rapid deliveries of blood, tech-friendly regulations, and autonomous weapons are all signs that drone technology is changing quickly.

The FDA is poised to approve the notorious party drug as a therapy. Here’s what it means, and where similar drugs stand in the US. 

If we want our vaccine production process to be more robust and faster, we’ll have to stop relying on chicken eggs.

How Big Tech, startups, AI devices, and trade wars will transform the way chips are made and the technologies they power.

OpenAI's Sora has raised the bar for AI moviemaking. Here are four things to bear in mind as we wrap our heads around what's coming.